Medial Temporal Lobectomy Aids Seizure Outcomes in Epilepsy
MONDAY, April 14, 2025 -- Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe epilepsy, according to a study published online March 6 in Cureus.
In a prospective cohort interventional study conducted in Egypt between 2022 and 2024, Sameh M. Salama, Ph.D., from the Al-Azhar University of Medicine in Cairo, and colleagues assessed epilepsy control after medial temporal lobectomy (with or without amygdalohippocampectomy) for management of drug-resistant temporal lobe epilepsy. Postoperative seizure control was evaluated using the Engel classification scale during follow-up and withdrawal of antiepileptic drugs.
The researchers found that seizure control improved after medial temporal lobectomy. At final follow-up, 15 respondents (75 percent) reached Engel class I (no seizures) and five respondents (25 percent) reached Engel class II (rare, nondisabling seizures).
"These results support surgical management as an essential treatment option for medically refractory epilepsy and highlight the importance of identifying patients for early surgical evaluation," Salama and colleagues conclude. "More studies with bigger sample sizes along with extended follow-up periods should be performed to improve patient selection criteria and surgical methods that enhance patient outcomes."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Slightly More Than Half of Pregnant Women With Epilepsy See Neurologist in Year Predelivery
FRIDAY, Sept. 19, 2025 -- Just over half (55 percent) of pregnant women with epilepsy (WWE) saw a neurologist in the year prior to delivery, according to a study presented at the...
Prefrontal Cortex Can Be Safely Biopsied During Deep Brain Stimulation
WEDNESDAY, Sept. 3, 2025 -- Obtaining a prefrontal cortex (PFC) biopsy during deep brain stimulation (DBS) procedures is safe, according to a study published online Sept. 3 in...
Treatment Response to Antiseizure Medications Can Take More Than One Year
WEDNESDAY, Aug. 27, 2025 -- Many people with newly diagnosed focal episodes take more than one year and more than one antiseizure medication (ASM) to become seizure-free...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.